Olema Pharmaceuticals (OLMA) Shares Outstanding (2020 - 2026)
Olema Pharmaceuticals (OLMA) has 7 years of Shares Outstanding data on record, last reported at $87.3 million in Q1 2026.
- On a quarterly basis, Shares Outstanding rose 27.8% to $87.3 million in Q1 2026 year-over-year; TTM through Mar 2026 was $87.3 million, a 27.8% increase, with the full-year FY2025 number at $81.4 million, up 9.51% from a year prior.
- Shares Outstanding reached $87.3 million in Q1 2026 per OLMA's latest filing, up from $81.4 million in the prior quarter.
- Over the last five years, Shares Outstanding for OLMA hit a ceiling of $87.3 million in Q1 2026 and a floor of $39.9 million in Q1 2022.
- A 5-year average of $57.1 million and a median of $55.9 million in 2024 define the central range for Shares Outstanding.
- Peak YoY movement for Shares Outstanding: grew 1.02% in 2022, then skyrocketed 39.21% in 2024.
- Tracing OLMA's Shares Outstanding over 5 years: stood at $40.3 million in 2022, then skyrocketed by 36.5% to $55.0 million in 2023, then skyrocketed by 35.13% to $74.3 million in 2024, then grew by 9.51% to $81.4 million in 2025, then grew by 7.32% to $87.3 million in 2026.
- Business Quant data shows Shares Outstanding for OLMA at $87.3 million in Q1 2026, $81.4 million in Q4 2025, and $68.7 million in Q3 2025.